Necitumumab

PORTRAZZA 800mg concentrado para solucion para perfusion

800 mg concentrado para solución para perfusiónSpainWithdrawnAuthorised 7 Mar 2016

Product informationAsk Osler about it

This page is kept for reference and is not offered to search engines.

In other countries

The same active substances on other registers, the same brand first.

Authorised centrally in the EU

This national listing belongs to a medicine the European Commission authorised for the whole EU.

PortrazzaEuropean UnionWithdrawn

Packs

Two medicines in one question?

Name two or more medicines and Osler runs an interaction check. A severe interaction is stated at the very top of the answer.

Discover Osler

Necitumumab

PORTRAZZA 800mg concentrado para solucion para perfusion

800 mg concentrado para solución para perfusiónSpainWithdrawnAuthorised 7 Mar 2016

Product informationAsk Osler about it

This page is kept for reference and is not offered to search engines.

In other countries

The same active substances on other registers, the same brand first.

Authorised centrally in the EU

This national listing belongs to a medicine the European Commission authorised for the whole EU.

PortrazzaEuropean UnionWithdrawn

Packs

Two medicines in one question?

Name two or more medicines and Osler runs an interaction check. A severe interaction is stated at the very top of the answer.

Discover Osler

Pack	Code	Status
PORTRAZZA 800mg concentrado para solucion para perfusion 50 ml	710286

Documents

The official texts, at the regulator.

Sources and licences

Compiled by Prognia from the public register below; the register’s text is the official one.

Agencia Española de Medicamentos y Productos Sanitarios

Fuente de la información: Agencia Española de Medicamentos y Productos Sanitarios www.aemps.gob.es; CIMA medicamentos, acquired 11 October 2026 UTC; each source response/update date retained.

Licence: AEMPS explicit public open-data reuse for citizens and companies; source attribution and update date required · Added 12 Oct 2026

Report an error or request removalCorrections from the holder or the register are welcome.

Prognia shows this product information for reference and learning. It is not treatment advice and can lag behind the official text. Always check the current product information and local protocols before prescribing.

At a glance

Active substance: Necitumumab
Strength: 800 mg
Dosage form: concentrado para solución para perfusión
Route: vía intravenosa
Register: Spain (AEMPS)
Status: Withdrawn
Status in the register: Revocado
Authorised: 7 Mar 2016
Registration: 1151084001
Marketing authorisation holder: Eli Lilly Nederland B.V.
Procedure: EU centralised
Supply: Uso Hospitalario
EU number: EU/1/15/1084